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1. Introduction
A variety of materials have been used for replace-
ment and repair of damaged or traumatized tissues
[1–8].These materials include metals, ceramics,
polymers (natural and synthetic) and their combina-
tions. Polymers have great design flexibility because
their composition and structure can be tailored to
the specific needs [9, 10]. They are therefore attrac-
tive candidates for various clinical applications.
Synthetic biodegradable polymers, poly (esters)
based on polylactide (PLA), polyglycolide (PGA),
polycaprolactone (PCL) and their copolymers are
approved by the World Health Organization (WHO)
and Food and Drug Administration (FDA) as mate-
rials that can be used in medicine and pharmacy
[11–14]. Poly (DL-lactide-co-glycolide) (PLGA), a
biocompatible and biodegradable copolymer of
PLA and PGA, is widely used in various medical
applications; controlled release of delivering drugs,
scaffolds in the tissue engineering, fixation of bone
fractures, chirurgical strings, etc. [15–17]. PLGA
particles are used for the controlled delivery of sev-
eral types of medicaments, including anticancer
agents, antihypertensive agents, immunomodula-
tory drugs, hormones, vitamins, etc. [18–20].
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© BME-PTScaffold provides temporary support for cell prolif-
eration and differentiated function, allowing neotis-
sue formation and initial remodeling [19]. The
choice of the best scaffold for a particular tissue
engineering application and how to change an exist-
ing scaffold to improve its performance are impor-
tant components of any tissue engineering research
project [19]. Numerous techniques have been used
for scaffold design, such as solvent casting/particu-
late leaching, phase separation, microsphere sinter-
ing, electrospining, emulsion freeze drying, fiber
extrusion, gas foaming and 3-D printing [19–21].
Many factors are important when designing materi-
als for use in biomedicine. The main advantage of
nano and microspheres used in tissue engineering,
compared to the more traditional macroporous
block scaffolds, is that nano and microspheres pos-
sess not only better drug-delivery properties, but
also the ability to fill the bone defects with irregular
and complex shapes and sizes [22]. The interstitial
space between the particles of the microspheres is
crucial for effective and functional bone regenera-
tion [22–24] as they allow for both bone and vascu-
lar ingrowths. Appropriate porosity is a crucial bio-
material design criterion for materials used in tissue
engineering applications as it can allow increased
cell adhesion, migration, proliferation and extracel-
lular matrix production within the scaffold at a tis-
sue defect site [25].
In controlled drug delivery porosity is also a very
important factor influencing the degradation process
of poly(DL-lactide-co-glycolide). The presence of
pores does not only increase the mobility of the
involved species (drug molecules, acids and bases),
but fundamentally alters the underlying drug release
mechanisms. Generally, the release of medicament
during the degradation process will be faster in case
of porous particles. A factor related to the sphere
porosity is, also, the initial burst effect, which cor-
responds to the rapid initial release of drug and is
normally followed by the relatively controlled lin-
ear release [26].
The goal of the study reported here was to investi-
gate the influence of different porogens on the mor-
phological characteristics and formation of pores in
PLGA based materials, nano and microspheres
obtained by physicochemical solvent/non-solvent
method, and also very important to eliminate the
release-delayed phenomenon of macromolecular
drug delivery system at the early stage of the degra-
dation. Porous, PLGA materials were prepared with
polyvinyl pyrrolidone (PVP) as a stabilizer and
with silicone oil, paraffin, hydrogen peroxide or
sodium chloride as a porogen. PVP acting as stabi-
lizer and dispersant i.e. has role to prevent coales-
cence or aggregation of the particles. In the process
of the preparation of the porous PLGA, we have
obtained non-particulate templates in the forms of
porous films and scaffolds. Using the synthesis pro-
tocol nanoparticulate PLGA materials were obtained
only in the absence of porogens [27]. Since the
recent studies have pointed out that the higher toxic
potential of nanomaterials in comparison to their
larger counterparts is most probably due to oxida-
tive stress as a consequence of increased production
of reactive oxygen species (ROS) [28, 29], it is very
important to establish ROS-inducing potential of
our model nanomaterial, PLGA nanospheres, which
is determined in this paper.
2. Experimental
2.1. Materials
Poly(DL-lactide-co-glycolide) (PLGA) was pur-
chased from Durect, Lactel (Birmingham, Ala-
bama, USA) and had a lactide-to-glycolide ratio of
50:50. Molecular weight of the polymer is 40000–
50000 g/mol. The time for its complete resorption
in the body is 4 to 8 weeks. Polyvinyl pyrrolidone
(povidone, PVP) was obtained from Merck Chemi-
cals Ltd (k-25, Merck, Germany). Silicon oil, sodium
chloride, hydrogen peroxide (all from Centrohem,
Serbia) and paraffin (melting point 53–57ºC, Merck,
Germany) were used as porogens. Cyclohexane
(boiling point 81°C, Merck, Germany), n-heptane
(Centrohem, Serbia) and distilled water were used
as solvents of a porogens.
The degradation medium used was phosphate
buffered saline (PBS, one tablet dissolved in 200 ml
of deionized water yields 0.137 mol/l sodium chlo-
ride, 0.01 mol/l phosphate buffer and 0.0027 mol/l
potassium chloride, pH is 7.4 at 25°C, Sigma-
Aldrich, St. Louis, USA) with sodium azide (Sigma-
Aldrich Chemie GmbH Germany ), 0.1 mol/l solu-
tion NaN3).
Chemicals for determining intracellular reactive
oxygen species formation (DCFH-DA assay) [30],
Minimal Essential Medium Eagle, penicillin/strep-
tomycin, L-glutamine, phosphate buffered saline,
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acid solution (100!), and 2,7-dichlorofluorescein
diacetate (DCFH-DA) were obtained from Sigma
Aldrich (St. Louis, USA).
2.2. Preparation of PLGA nanospheres and
preparation of porous PLGA samples by
different porogens and different solvents
of the porogens
PLGA nano and microparticles were synthesized
following method previously described in our work
[31] i.e. by using physicochemical method with sol-
vent/nonsolvent systems where obtained solutions
were centrifuged. Polyvinyl pyrrolidone was used
as a stabilizer of the particles.
Briefly, commercial granules poly(D,L-lactide-co-
glycolide) (250 mg) have been dissolved in the ace-
tone (20 ml) and, after approximately two hours,
ethanol (25 ml) has been added into the solvent
mixture. PLGA was precipitated by the addition of
ethanol and the solution became whitish. The poly-
meric solution thus obtained has been very slowly
poured into aqueous PVP solution (0.05% w/w)
while continuously stirring at 1200 rpm by a stirrer.
After that porogen (silicon oil, paraffin, hydrogen
peroxide or sodium chloride) has been added into
the mixture and then the solution has been cen-
trifuged at 6000 rpm and at 5ºC for 120 min (Uni-
versal 320R, Hettich, Germany) and decanted. In
all experiments PLGA:porogen ratio was 1:10. This
ratio was used because; in case porogen content is
sufficiently high, the resulting pores must be with
some interconnectivity simply due to geometrical
packing. The sediment was placed into the Petri
dish and allowed to dry overnight at room tempera-
ture. The dried polymer films were removed from
the Petri dish and soaked in appropriate solvent for
72 h to remove the porogen. The solvent was
changed, approximately, every 12 h to allow the
porogen to leach out. Paraffin as porogen has been
removed from polymeric film with cyclohexane,
silicone oil with n-heptan and sodium chloride with
distilled water. This was repeated several times to
remove the porogen in its entirety. PLGA films
were vacuum dried (Vaciotem P-Selecta) for 48 h to
allow the solvent to evaporate.
2.3. The structural analysis of the samples
In order to investigate the characteristics of the
PLGA particles and PLGA porous materials obtained
with different porogens i.e. to confirm the quality
composition of the samples, X-ray diffraction
(XRD) has been used. Phase analyses were per-
formed by XRD, using a Philips PW 1050 diffrac-
tometer with Cu-K"1,2 radiation (Ni filter). Meas-
urements were done in 2# range of 10–70° with
scanning step width of 0.05° and 2 s of time per
step.
The quality analysis of the samples was, also, per-
formed using IR spectroscopy. IR spectra were
recorded in the range of 400–4000 cm–1 at a MIDAC
M 2000 Series Research Laboratory FTIR Spec-
trometer, at 4 cm–1 resolution.
2.4. Zeta potential measurements
Zeta potential was measured by Zetasizer (Nano
ZS, Model ZEN3600, particles size range for zeta
potential determination (5 nm–10 µm), Malvern
Instruments, Malvern, UK) using the principle of
electrophoretic mobility under an electric field.
Zeta potential is the function of dispersion/suspen-
sion pH which determines particle stability in dis-
persion.
2.5. Determining intracellular reactive oxygen
species formation – DCFH-DA assay
The formation of intracellular reactive oxygen
species (ROS) was measured spectrophotometri-
cally using a fluorescent probe, DCFH-DA as
described by Osseni et al. [30], with minor modifi-
cations [32]. DCFH-DA readily diffuses through
the cell membrane and is hydrolyzed by intracellu-
lar esterases to non-fluorescent 2#,7#-dichlorofluo-
rescin. It is then rapidly oxidized to highly fluores-
cent 2#,7#-dichlorofluorescein in the presence of
ROS. The DCF fluorescence intensity is propor-
tional to the amount of reactive oxygen species
formed intracellularly. H2O2 is the principle ROS
responsible for the oxidation of DCFH-DA to DCF
[33].
In this assay we used cells HepG2, which were
grown in Minimal Essential Medium Eagle medium
containing 10% foetal bovine serum, 1% non-essen-
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100 U/ml penicillin plus 100 µg/ml streptomycin at
37°C in humidified atmosphere and 5% CO2. 
HepG2 cells were seeded at a density of
75000 cells/ml into 96-well, black, tissue culture
treated microtiter plates (Nunc, Naperville IL,
USA) in five replicates. After 20 h of incubation at
37°C in 5% CO2, cells were incubated with 20 µM
DCFH-DA. After 30 min, DCFH-DA was removed
and cells were treated with 0, 1, 10, 25, 50 and
66,5 µg/ml of PLGA nanoparticles without poro-
gens in PBS. In each experiment were included
negative control (non-treated cells), positive control
(0,5 mM t-BOOH) and a vehicle control (5% emul-
sion; emulsion consists of acetone, ethanol and PVP,
in the same ratio as used in the experiment, without
PLGA) in order to exclude possible effects of the
solvent (emulsion). For kinetic analyses the dishes
were maintained at 37°C and the fluorescence inten-
sity was determined every 30 min during the 5 h
incubation using a microplate reading spectrofluo-
rimeter (Tecan, Genios) at the excitation wave-
length of 485 nm and the emission wavelength of
530 nm.
Statistical significance between treated groups and
controls was determined by two tailed Student’s t-
test and P<0.05 was considered as statistically sig-
nificant. Two independent experiments with five
replicates were performed.
In our study we tested ROS-inducing potential of
PLGA nanoparticles without porogens only and we
did not test ROS-inducing potential of porous
PLGA material, since it is much more difficult to
perform testing of material in form of the scaffold
than of particles that can be dispersed. Testing of
materials in the form of scaffold requires seeding of
cells onto material surface instead of seeding onto
plastic surfaces, which is regularly used for in vitro
toxicology tests. For the analysis of ROS-inducing
potential of such material it is necessary to detach
the cells from the material (with trypsinization or
cell scraping), process that itself generates cellular
oxidative stress and result in artificial changes in
fluorescence, due to which we can observe false
positive results. Because of this we tested only
ROS-inducing potential of PLGA nanoparticles
without porogens.
2.6. Morphology studies
The morphology of obtained nano and microparti-
cles and porous samples was evaluated by scanning
electron microscope (SEM) (JEOL JSM-639OLV)
and SUPRA 35 VP Carl Zeiss field emission scan-
ning electron microscope (FESEM). The powder
samples for SEM analysis were coated with gold
using the physical vapour deposition (PVD) process.
Samples were covered with gold (Baltec SCD 005
sputter coater), using 30 mA current from the dis-
tance of 50 mm during 180 s. SEM recordings were,
also, used to obtain information about profiles and
sizes of the particles and pores.
2.7. Water absorption
Water absorption of the polymeric films or scaf-
folds was measured in the manner described in
detail elsewhere [34–38]. Water absorption was
measured by immersing the samples in distilled
water for a predetermined time span (55 hours), then
the samples were taken out and dried by removing
the free water on the surface with filter paper and
weighed (W1). Then the samples were thoroughly
vacuum-dried and weighed again (W2). The water
absorption could be calculated as shown in Equa-
tion (1) and five specimens were averaged.
    (1)
2.8. In vitro degradation studies 
The degradation of PLGA nanoparticles and PLGA
porous materials obtained with sodium chloride as
porogen were studied during the 39 days in phos-
phate buffered saline as a degradation medium.
Taking into account that the degradation products
of PLGA, among others, are lactic and glycolic acid
[31], a calibration curve for lactic acid was made.
By tracking the increase of the concentration of lac-
tic acid in the solution, the degradation of the sam-
ples was monitored.
The concentration of lactic acid in the phosphate
buffered saline as a release medium was determined
by UV spectroscopy. Based on measuring absorbance
of the solution with a known concentration of lactic
acid at 220 nm, a calibration curve was prepared.
The linear relationship between light absorbance at
Water absorption 3,4 5
W1 2 W2
W2
·100 Water absorption 3,4 5
W1 2 W2
W2
·100
                                           Stevanovi! et al. – eXPRESS Polymer Letters Vol.5, No.11 (2011) 996–1008
                                                                                                    999220 nm and lactic acid concentration is shown
according to the Beer-Lambert Law (Equation (2)):
A = $cl                                                                  (2)
where A is absorbance at sample concentration c (in
this case concentration of the lactic acid [mg/ml]),
l is path length of quartz cell and $ is the absorptiv-
ity. By applying this standardized relationship, PBS
solution, in which the samples were suspended, was
analyzed to determine the concentration and amount
of lactic acid as product of the degradation of
PLGA samples whether it is porous or whether it is
not porous. The in vitro degradation of PLGA nano  -
particles and PLGA porous materials obtained with
sodium chloride as porogen was studied by sus-
pending samples in PBS in the absence of light at
37±1ºC (VIMS elektrik, SCG). Measurements of
the degradation of both samples were undertaken
by exposing 2 mg of the sample to 2 ml of PBS.
The UV measurements were performed on GBC,
Cintra 101 UV-VIS Spectrophotometer in the fre-
quency interval of 200–400 nm.
2.9. pH measurements
The pH of the physiological solution has been
measured using pH indicator strips obtained from
Merck (KGaA, Germany) at various time periods
(during the 39 days) to follow the acidity of the
degrading medium with time.
3. Results and discussion
3.1. The structural analysis of the samples
The IR spectra illustrate all characteristic groups for
copolymer poly(DL-lactide-coglycolide). The IR
spectra of PLGA show peaks at 2995, 2948 ,
2841 cm–1 (C–H bend of the –CH2 and  –CH3
group), 1769 cm–1 (C=O ester), 1461, 1425,
1370 cm–1 (C–H bend of the CH3 group), 1150,
1069, 987 cm–1 (C–O stretch), 735, 510 cm–1 (C–H
bend). The IR spectra, also, shows a broad band in
the range 3100–3600 cm–1 which belongs to the
OH$ group of the water molecule [39, 40].
The X-ray diffractograms of PLGA nanoparticles
and PLGA porous materials are presented in Fig-
ure 1. PLGA did not exhibit any crystalline peak
under the present experimental conditions because
PLGA is amorphous. Also, X-ray patterns show that
there is no presence of residual porogens in the
samples (Figure 1b–d). On the Figure 1e strong
background and the up-shift of the broad structure
can be observed. We may assume this is probably
related to residual sodium chloride. However, as
known from the literature [41], sodium chloride is
crystalline and has strong peaks at 2# = 31.8, 45.6
and 66.2º assigned to (200), (400) and (220) planes
respectively, which are not present. Thus we con-
clude the amount of the residual sodium chloride is
negligible.
3.2. Zeta potential measurements
PVP was used as a stabilizer which creates nega-
tively charged PLGA particles, that is, induces a
specific zeta potential. PVP reduces the agglomera-
tion because the particles of the same charge are not
attracted to each other. A refractive index (RI) value
of 1.4 was used in determination of the size of
nanoparticles. The RI value is estimated from prod-
uct literature values for the RI of polylactic acid
(1.35–1.45, Natureworks LLC) and for the monomers
(lactic acid = 1.42, glycolic acid = 1.41, Sigma-
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Figure 1. XRD patterns of a) PLGA particles prepared
without porogen, b) PLGA obtained with silicone
oil as porogen and n-heptan as solvent of the
porogen; c) PLGA obtained with paraffin as poro-
gen and cyclohexane as solvent of the porogen;
d) PLGA obtained with hydrogen peroxide and
e) PLGA obtained with sodium chloride as poro-
gen and water as solvent of the porogen
Table 1. Zeta potential of PLGA dispersion and size of PLGA particles in dispersion
Values given are mean ± standard deviation (n = 5).
Particle size [nm] pH Polydispersity index Zeta potential [mV]
PLGA2 275±5 4.30–4.37 0.053 –9.5±0.3Aldrich Corp.) [42]. The polydispersity index (PDI)
which is a dimensionless number indicating the
width of the size distribution, having a value
between 0 and 1 (0 being for monodispersed parti-
cles) was also obtained (Table 1).
Values for the size of particles from the dispersion
of the same sample determined by Malvern particle
analyzer were bigger from the values obtained by
SEM for particles of the powder of the same sam-
ple. The reason is, as we reported earlier [43], that
time and velocity of centrifugal processing influ-
ences the morphology (size and shape) and unifor-
mity of PLGA polymer powder. An influence of the
centrifugation process on the particle sizes is sup-
ported by the fact that coefficient of friction for
smaller and more compact spherical particles is less
than those with irregular shapes and same mass,
which makes spherical particles sediment faster
[43]. Also, values for sizes of the particles in the
dispersion can be bigger because of the hydrody-
namic effect, layer of ions around the particles,
aggregates of the particles, etc [44].
3.3. Induction of intracellular ROS formation
HepG2 cells are of human origin and retain many of
the specialized liver functions and drug metaboliz-
ing enzyme activities present in human hepato-
cytes. They are considered to better reflect the
processes in normal human liver than other in vitro
toxicity test systems. In our previous study we have
shown that exposure of HepG2 cells to 0, 1, 10, 25,
50 and 66,5 µg/ml of PLGA nanoparticles for 24 h
did not affect the viability of the cells [18]. There-
fore, these concentrations were used in further
experiments.
Exposure of HepG2 cells to PLGA nanoparticles
did not induce significant increase of DCF fluores-
cence intensity, while exposure to t-BOOH, the posi-
tive control, induced significant, up to six fold
increase in DCF fluorescence intensity over the
control, non-treated cells (Figure 2). Based on these
results we conclude that PLGA nanoparticles are
not inducers of intracellular ROS formation.
3.4. Morphology studies
The morphological characteristics of the particles
are extremely important for the controlled drug
delivery and tissue engineering and particularly
influence the adhesion and interaction with cells
(intracellular uptake). Dynamics of the release (rate
and concentration) depends on the morphology, i.e.
structure of the copolymer.
The morphological characteristics of PLGA parti-
cles and PLGA porous materials obtained with dif-
ferent porogens, were observed by a scanning elec-
tron microscope. Different morphologies of PLGA
were prepared using no porogen, and silicon oil,
paraffin, hydrogen peroxide or sodium chloride as
porogens. By using different porogens the samples
with diferent morphological characteristics, at
macroscopic and as well on microscopic level, were
obtained.
From the micrograph of non-porous PLGA particles
it is visible the particles have spherical shape,
smooth surface, low level of agglomeration and high
level of uniformity (Figure 3). The size distribution
of all nanoparticles was unimodal with sizes of
about 100–200 nm. The particles are without cracks
and pores.
From SEM images of PLGA material obtained in the
experiment with silicone oil as porogen and n-hep-
tan as solvent of the porogen it is visible that use of
silicon oil as porogen has no major impact on the for-
mation of pores in the sample (Figure 4). The parti-
cles are much agglomerated and they create the
film. On the film cracks and roughness can be seen.
In the sample spherical particles of smaller and larger
sizes that are distributed sporadically are still present.
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Figure 2. PLGA-induced intracellular ROS formation in
HepG2 cells. The HepG2 cells were pretreated
with DCFH-DA (20 µM) for 30 min, washed and
then exposed to different concentrations of
PLGA (0, 1, 10, 25, 50 and 66,5 µg/ml) or
0,5 mM t-BOOH as the positive control (PC).
DCF fluorescence intensity was measured at
30 min intervals during the 5 h incubation. Each
point represents the mean of five replicates (±SD)
of two independent experiments. (*) denotes a
significant difference (p < 0,05).SEM images revealed porous morphologies of the
samples when paraffin was used in the experiment
as porogen and cyclohexane as solvent of the poro-
gen (Figure 5). We can see from SEM micrographs
that the resulting pores are with irregular shapes
and without a good interconnectivity.
Figure 6 shows SEM observation of the interior
pore structure of PLGA material obtained in the
experiment when hydrogen peroxide was used as
porogen. In this case the sample with high porosity
and with good interconnectivity was obtained. The
pores are with spherical but also irregular shapes.
The pore size has mean value of about 10 µm.
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Figure 3. FESEM images of PLGA particles obtained in the experiment without porogen (a–d)
Figure 4. SEM images of PLGA material obtained in the experiment with silicone oil as porogen and n-heptan as solvent of
the porogen (a–c)
Figure 5. SEM images of PLGA material obtained in the experiment with paraffin as porogen and cyclohexane as solvent
of the porogen (a–c)Figure 7a–b shows digital photographs of PLGA
material obtained with sodium chloride as porogen.
PLGA porous material appeared well formed and a
highly porous sponge-like where the pores are sim-
ilar in the size and shape.
The optimum morphological characteristics were
obtained when sodium chloride was used as pore
former. SEM micrographs showed that porous
PLGA scaffolds obtained in the experiment with
sodium chloride as porogen and water as solvent of
the porogen had apparently uniform pore morphol-
ogy with spheroidal pore in shape and well con-
trolled three-dimensional interconnected network
(Figure 7c–f). This PLGA samples are highly porous
with similar porosity values. The pore size varies
from 50 to 150 µm based on SEM images. The uni-
fied and well organized porous structure can be
seen. It is evident that pores have more precise con-
tours.
3.5. Water absorption
In the literature, it has been reported that wetting of
a polymer scaffold is very important for homoge-
neous and sufficient cell seeding throughout the
porous scaffold [38]. To evaluate hydrophilicity of
PLGA porous samples water absorption was meas-
ured. The water absorption of the samples changed
with their porosity (Figure 8). PLGA porous scaf-
folds obtained with sodium chloride as porogen
exhibited higher water absorption than other sam-
ples. It could be seen that the water absorption
increased with the degree of porosity increasing and
all the samples had higher water absorption than
non-porous PLGA.
3.6. Degradation studies
The degradation of PLGA particles and PLGA
porous materials obtained with sodium chloride as
porogen was measured in PBS as a degradation
                                           Stevanovi! et al. – eXPRESS Polymer Letters Vol.5, No.11 (2011) 996–1008
                                                                                                   1003
Figure 6. SEM images of PLGA material obtained in the experiment with hydrogen peroxide as porogen (a–i)medium during the 39 days (Table 2). By the end of
39 days, the samples have fully degraded and there
were no more traces of them in the solution. Litera-
ture describes two approaches for the study of poly-
meric degradation and they vary according to whether
examination is under dynamic or static conditions
[45]. In our case degradation of non-porous and
porous PLGA was measured under static condi-
tions. It was observed, the degradation medium, in
which porous PLGA was suspended, at the begin-
ning of the process of the degradation (measured in
the second day), contains much more lactic acid
than degradation medium in which PLGA nanopar-
ticles were suspended, which means porous PLGA
degrades faster (Table 2 gives cumulative concen-
trations of the released lactic acid). The release-
delayed phenomenon of macromolecular drug
delivery system at the early stage of the degradation
was eliminated in the case of porous PLGA
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Figure 7. a–b) Macroscopic observation of PLGA scaffold obtained with NaCl as pore former and c–f) SEM images of
PLGA material obtained in the experiment with sodium chloride as porogen and water as solvent of the porogen
Figure 8. Change of water absorption of various PLGA
porous samples in comparison with non-porous
PLGA as function of time: a) non-porous PLGA
particles; b) porus PLGA material obtained with
silicone oil as porogen and n-heptan as solvent of
the porogen; c) with paraffin as porogen and
cyclohexane as solvent of the porogen; d) with
hydrogen peroxide as porogen and e) with
sodium chloride as porogen and water as solvent
of the porogenobtained with sodium chloride as porogen and
water as solvent of the porogen. The explanation for
this phenomenon is very simple. During the degra-
dation process the non-porous PLGA particles are
in a very close contact which brings to higher
agglomeration of the particles and creation of the
porous film [18]. The degradation of the PLGA
becomes faster when the degradation medium passes
through the polymeric membrane, i.e. the degrada-
tion is more rapid when polymeric film becomes
sufficiently porous. We have already elaborated this
process elsewhere [18]. The sample obtained in the
experiment with sodium chloride as porogen and
water as solvent of the porogen has already porous
structure so degradation becomes more rapid with-
out delay, i.e. immediately and so the release of,
potentially encapsulated, drug will be starting, also,
without delay.
3.7. pH measurements
The pH of PBS solution has begun to decrease,
approximately, after 48hrs of storage, in the case of
porous PLGA when sodium chloride was used as
pore former as well as in the case of non-porous
PLGA (Figure 9). This is presumably due to an
accumulation of lactic and glycolic acid. PLGA
degrades via backbone hydrolysis (bulk erosion)
and the degradation products are the monomers, lac-
tic acid and glycolic acid. It could be expected that
the faster degradation of the lower molar mass frac-
tion, present in copolymer, increases the local acid-
ity, thereby, accelerating the hydrolysis of higher
molar mass species. In another words, when acid
accumulation creates a local pH drop, catalytic
degradation of the polymer itself occurs [24]. The
pH of PBS medium in which porous PLGA scaffold
was stored decreases faster at the beginning of the
degradation and the reason for these phenomena is
that the degradation medium diffuse through the
sample i.e. medium passes into pores of the sample.
Also, as already noted, PLGA porous scaffolds
obtained with sodium chloride as porogen exhibited
higher water absorption than other samples and
degradation medium in which PLGA porous scaf-
folds were suspended contains more lactic acid
after two days of the degradation. In the case of non-
porous PLGA, during the degradation process the
particles are in a very close contact which leads to
higher agglomeration of the particles and formation
of the porous film [18]. The degradation becomes
more rapid when polymeric film becomes suffi-
ciently porous. Because of that, after approximately
20 days, degradation of newly generated porous film
(initially non-porous PLGA particles) becomes faster
and thus it comes to a faster decrease of pH than in
the case of pH of the porous PLGA scaffold. Thin
PLGA films degraded faster than thick scaffold
because thin films had a greater surface area to vol-
ume ratio and thus a greater extent of degradation
medium uptake.
4. Conclusions
The physicochemical method has produced non-
agglomerated PLGA nanospheres with spherical
and uniform shapes. We have shown that PLGA
nanospheres are not cytotoxic and they do not induce
increased production of ROS for HepG2 cells in
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Table 2. The concentration of lactic acid calculated on the basis of absorbance at the wavelength of absorption maximum at
220 nm from spectra recorded after 39 days of the degradation and calibration curve for lactic acid
The data are presented as mean values of three independent
Absorbance at 220 nm Concentration [mg/ml]
After two days After 39 days After two days After 39 days
PLGA 0.068 0.507 0.07 1.00
Porous PLGA (NaCl as pore former) 0.242 0.561 0.42 1.12
Figure 9. Changes in the pH of the degradation medium
with time for the PLGA in the case of a) non
porous PLGA nanoparticles and b) porous PLGA
obtained when sodium chloride was used as pore
formevitro, which is an optimistic result for usage of PLGA
nanospheres for in vivo applications. Porous poly
(DL-lactid-co-glycolid) materials were fabricated
using different porogens, silicon oil, paraffin, hydro-
gen peroxide or sodium chloride. It was found that
silicon oil as porogen has no major impact on the
formation of pores in the sample. Paraffin leads to
the formation of pores with irregular shapes and
without a good interconnectivity. When hydrogen
peroxide was used as porogen, sample with high
porosity and with good interconnectivity was
obtained but pore size has mean value only of about
10 µm. SEM micrographs showed that porous PLGA
scaffolds obtained in the experiment with sodium
chloride as porogen and water as solvent of the
porogen had apparently uniform pore morphology
with spherical pore in shape and well controlled
three-dimensional interconnected network. These
PLGA samples are highly porous with similar
porosity values and exhibit higher water absorption
than porous samples obtained with another poro-
gens. To eliminate the release-delayed phenomenon
of PLGA macromolecular drug delivery system at
the early stage, biodegradable implantable drug
delivery system with porous structure was designed
when sodium chloride was used as pore former and
by physicochemical solvent/non-solvent method. An
important clinical application of this porous PLGA
material is reflected in the case of many chronic
diseases where long term therapy is needed, but one
has to start treatment immediately. Besides for the
controlled delivery of drugs, this porous material is
also very suitable in many other biomedical appli-
cations, for example in tissue engineering because
it provides the required properties needed for the
survival of cells (cell adhesion, proliferation, migra-
tion, and/or differentiation) and formation of tissue.
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